Structural basis of AMPK regulation by small molecule activators

Abstract

AMP-activated protein kinase (AMPK) plays a major role in regulating cellular energy balance by sensing and responding to increases in AMP/ADP concentration relative to ATP. Binding of AMP causes allosteric activation of the enzyme and binding of either AMP or ADP promotes and maintains the phosphorylation of threonine 172 within the activation loop of the kinase. AMPK has attracted widespread interest as a potential therapeutic target for metabolic diseases including type 2 diabetes and, more recently, cancer. A number of direct AMPK activators have been reported as having beneficial effects in treating metabolic diseases, but there has been no structural basis for activator binding to AMPK. Here we present the crystal structure of human AMPK in complex with a small molecule activator that binds at a site between the kinase domain and the carbohydrate-binding module, stabilising the interaction between these two components. The nature of the activator-binding pocket suggests the involvement of an additional, as yet unidentified, metabolite in the physiological regulation of AMPK. Importantly, the structure offers new opportunities for the design of small molecule activators of AMPK for treatment of metabolic disorders.

References 58

1. 1.

   Carling D., Mayer F. V., Sanders M. J. & Gamblin S. J. AMP-activated protein kinase: nature's energy sensor. Nat. Chem. Biol. 7, 512–518 (2011 ).

   Not in our library10.1038/nchembio.610

2. 2.

   Hardie D. G., Carling D. & Gamblin S. J. AMP-activated protein kinase: also regulated by ADP? Trends. Biochem. Sci. 36, 470–477 (2011 ).

   Not in our library10.1016/j.tibs.2011.06.004

3. 3.

   Oakhill J. S., Scott J. W. & Kemp B. E. AMPK functions as an adenylate charge-regulated protein kinase. Trends. Endocrinol. Metab. 23, 125–132 (2012 ).

   Not in our library10.1016/j.tem.2011.12.006

4. 4.

   Hawley S. A.. Characterization of the AMP-activated protein kinase kinase from rat liver and identification of threonine 172 as the major site at which it phosphorylates AMP-activated protein kinase. J. Biol. Chem. 271, 27879–27887 (1996 ).

   Not in our library10.1074/jbc.271.44.27879

5. 5.

   Hawley S. A.. Complexes between the LKB1 tumor suppressor, STRAD alpha/beta and MO25 alpha/beta are upstream kinases in the AMP-activated protein kinase cascade. J. Biol. 2, 28 (2003 ).

   Not in our library10.1186/1475-4924-2-28

6. 6.

   Hong S. P., Leiper F. C., Woods A., Carling D. & Carlson M. Activation of yeast Snf1 and mammalian AMP-activated protein kinase by upstream kinases. Proc. Natl Acad. Sci. USA 100, 8839–8843 (2003 ).

   Not in our library10.1073/pnas.1533136100

7. 7.

   Shaw R. J.. The tumor suppressor LKB1 kinase directly activates AMP-activated kinase and regulates apoptosis in response to energy stress. Proc. Natl Acad. Sci. USA 101, 3329–3335 (2004 ).

   Not in our library10.1073/pnas.0308061100

8. 8.

   Woods A.. LKB1 is the upstream kinase in the AMP-activated protein kinase cascade. Curr. Biol. 13, 2004–2008 (2003 ).

   Not in our library10.1016/j.cub.2003.10.031

9. 9.

   Hawley S. A.. Calmodulin-dependent protein kinase kinase-beta is an alternative upstream kinase for AMP-activated protein kinase. Cell Metab. 2, 9–19 (2005 ).

   Not in our library10.1016/j.cmet.2005.05.009

10. 10.

    Woods A.. Ca2+/calmodulin-dependent protein kinase kinase-beta acts upstream of AMP-activated protein kinase in mammalian cells. Cell Metab. 2, 21–33 (2005 ).

    Not in our library10.1016/j.cmet.2005.06.005

11. 11.

    Hurley R. L.. The Ca2+/calmodulin-dependent protein kinase kinases are AMP-activated protein kinase kinases. J. Biol. Chem. 280, 29060–29066 (2005 ).

    Not in our library10.1074/jbc.m503824200

12. 12.

    Davies S. P., Carling D., Munday M. R. & Hardie D. G. Diurnal rhythm of phosphorylation of rat liver acetyl-CoA carboxylase by the AMP-activated protein kinase, demonstrated using freeze-clamping. Effects of high fat diets. Eur. J. Biochem./FEBS 203, 615–623 (1992 ).

    Not in our library10.1111/j.1432-1033.1992.tb16591.x

13. 13.

    Arad M., Seidman C. E. & Seidman J. G. AMP-activated protein kinase in the heart: role during health and disease. Circ. Res. 100, 474–488 (2007 ).

    Not in our library10.1161/01.res.0000258446.23525.37

14. 14.

    Carling D., Thornton C., Woods A. & Sanders M. J. AMP-activated protein kinase: new regulation, new roles? Biochem. J. 445, 11–27 (2012 ).

    Not in our library10.1042/bj20120546

15. 15.

    Hardie D. G., Ross F. A. & Hawley S. A. AMP-activated protein kinase: a target for drugs both ancient and modern. Chem. Biol. 19, 1222–1236 (2012 ).

    Not in our library10.1016/j.chembiol.2012.08.019

16. 16.

    Lage R., Dieguez C., Vidal-Puig A. & Lopez M. AMPK: a metabolic gauge regulating whole-body energy homeostasis. Trends. Mol. Med. 14, 539–549 (2008 ).

    Not in our library10.1016/j.molmed.2008.09.007

17. 17.

    Mihaylova M. M. & Shaw R. J. The AMPK signalling pathway coordinates cell growth, autophagy and metabolism. Nat. Cell Biol. 13, 1016–1023 (2011 ).

    Not in our library10.1038/ncb2329

18. 18.

    Richter E. A. & Ruderman N. B. AMPK and the biochemistry of exercise: implications for human health and disease. Biochem. J. 418, 261–275 (2009 ).

    Not in our library10.1042/bj20082055

19. 19.

    Steinberg G. R. & Kemp B. E. AMPK in health and disease. Physiol. Rev. 89, 1025–1078 (2009 ).

    Not in our library10.1152/physrev.00011.2008

20. 20.

    Viollet B.. AMPK inhibition in health and disease. Crit. Rev. Biochem. Mol. Biol. 45, 276–295 (2010 ).

    Not in our library10.3109/10409238.2010.488215

21. 21.

    Carling D.. Mammalian AMP-activated protein kinase is homologous to yeast and plant protein kinases involved in the regulation of carbon metabolism. J. Biol. Chem. 269, 11442–11448 (1994 ).

    Not in our library

22. 22.

    Davies S. P.. Purification of the AMP-activated protein kinase on ATP-gamma-sepharose and analysis of its subunit structure. Eur. J. Biochem. 223, 351–357 (1994 ).

    Not in our library10.1111/j.1432-1033.1994.tb19001.x

23. 23.

    Mitchelhill K. I.. Mammalian AMP-activated protein kinase shares structural and functional homology with the catalytic domain of yeast Snf1 protein kinase. J. Biol. Chem. 269, 2361–2364 (1994 ).

    Not in our library

24. 24.

    Stapleton D.. Mammalian 5'-AMP-activated protein kinase non-catalytic subunits are homologs of proteins that interact with yeast Snf1 protein kinase. J. Biol. Chem. 269, 29343–29346 (1994 ).

    Not in our library

25. 25.

    Stapleton D.. Mammalian AMP-activated protein kinase subfamily. J. Biol. Chem. 271, 611–614 (1996 ).

    Not in our library10.1074/jbc.271.2.611

26. 26.

    Woods A.. Characterization of AMP-activated protein kinase beta and gamma subunits. Assembly of the heterotrimeric complex in vitro. J. Biol. Chem. 271, 10282–10290 (1996 ).

    Not in our library10.1074/jbc.271.17.10282

27. 27.

    Bateman A. The structure of a domain common to archaebacteria and the homocystinuria disease protein. Trends. Biochem. Sci. 22, 12–13 (1997 ).

    Not in our library10.1016/s0968-0004(96)30046-7

28. 28.

    Xiao B.. Structural basis for AMP binding to mammalian AMP-activated protein kinase. Nature 449, 496–500 (2007 ).

    Not in our library10.1038/nature06161

29. 29.

    Zhu L.. Structural insights into the architecture and allostery of full-length AMP-activated protein kinase. Structure 19, 515–522 (2011 ).

    Not in our library10.1016/j.str.2011.01.018

30. 30.

    Chen L.. AMP-activated protein kinase undergoes nucleotide-dependent conformational changes. Nat. Struct. Mol. Biol. 19, 716–718 (2012 ).

    Not in our library10.1038/nsmb.2319

31. 31.

    Carling D., Clarke P. R., Zammit V. A. & Hardie D. G. Purification and characterization of the AMP-activated protein kinase. Copurification of acetyl-CoA carboxylase kinase and 3-hydroxy-3-methylglutaryl-CoA reductase kinase activities. Eur. J. Biochem. 186, 129–136 (1989 ).

    Not in our library10.1111/j.1432-1033.1989.tb15186.x

32. 32.

    Cheung P. C., Salt I. P., Davies S. P., Hardie D. G. & Carling D. Characterization of AMP-activated protein kinase gamma-subunit isoforms and their role in AMP binding. Biochem. J. 346, (Pt 3): 659–669 (2000 ).

    Not in our library

33. 33.

    Oakhill J. S.. beta-Subunit myristoylation is the gatekeeper for initiating metabolic stress sensing by AMP-activated protein kinase (AMPK). Proc. Natl Acad. Sci. USA 107, 19237–19241 (2010 ).

    Not in our library10.1073/pnas.1009705107

34. 34.

    Oakhill J. S.. AMPK is a direct adenylate charge-regulated protein kinase. Science 332, 1433–1435 (2011 ).

    Not in our library10.1126/science.1200094

35. 35.

    Davies S. P., Helps N. R., Cohen P. T. & Hardie D. G. 5′-AMP inhibits dephosphorylation, as well as promoting phosphorylation, of the AMP-activated protein kinase. Studies using bacterially expressed human protein phosphatase-2C alpha and native bovine protein phosphatase-2AC. FEBS Lett. 377, 421–425 (1995 ).

    Not in our library10.1016/0014-5793(95)01368-7

36. 36.

    Sanders M. J., Grondin P. O., Hegarty B. D., Snowden M. A. & Carling D. Investigating the mechanism for AMP activation of the AMP-activated protein kinase cascade. Biochem. J. 403, 139–148 (2007 ).

    Not in our library10.1042/bj20061520

37. 37.

    Suter M.. Dissecting the role of 5'-AMP for allosteric stimulation, activation, and deactivation of AMP-activated protein kinase. J. Biol. Chem. 281, 32207–32216 (2006 ).

    Not in our library10.1074/jbc.m606357200

38. 38.

    Xiao B.. Structure of mammalian AMPK and its regulation by ADP. Nature 472, 230–233 (2011 ).

    Not in our library10.1038/nature09932

39. 39.

    Cool B.. Identification and characterization of a small molecule AMPK activator that treats key components of type 2 diabetes and the metabolic syndrome. Cell Metab. 3, 403–416 (2006 ).

    Not in our library10.1016/j.cmet.2006.05.005

40. 40.

    Giordanetto F. & Karis D. Direct AMP-activated protein kinase activators: a review of evidence from the patent literature. Expert opin. Ther. Patents 22, 1467–1477 (2012 ).

    Not in our library10.1517/13543776.2012.743994

41. 41.

    Goransson O.. Mechanism of action of A-769662, a valuable tool for activation of AMP-activated protein kinase. J. Biol. Chem. 282, 32549–32560 (2007 ).

    Not in our library10.1074/jbc.m706536200

42. 42.

    Sanders M. J.. Defining the mechanism of activation of AMP-activated protein kinase by the small molecule A-769662, a member of the thienopyridone family. J. Biol. Chem. 282, 32539–32548 (2007 ).

    Not in our library10.1074/jbc.m706543200

43. 43.

    Scott J. W.. Thienopyridone drugs are selective activators of AMP-activated protein kinase beta1-containing complexes. Chem. Biol. 15, 1220–1230 (2008 ).

    Not in our library10.1016/j.chembiol.2008.10.005

44. 44.

    Hudson E. R.. A novel domain in AMP-activated protein kinase causes glycogen storage bodies similar to those seen in hereditary cardiac arrhythmias. Curr. Biol. 13, 861–866 (2003 ).

    Not in our library10.1016/s0960-9822(03)00249-5

45. 45.

    Polekhina G.. AMPK beta subunit targets metabolic stress sensing to glycogen. Curr. Biol. 13, 867–871 (2003 ).

    Not in our library10.1016/s0960-9822(03)00292-6

46. 46.

    Polekhina G.. Structural basis for glycogen recognition by AMP-activated protein kinase. Structure 13, 1453–1462 (2005 ).

    Not in our library10.1016/j.str.2005.07.008

47. 47.

    Amodeo G. A., Rudolph M. J. & Tong L. Crystal structure of the heterotrimer core of Saccharomyces cerevisiae AMPK homologue SNF1. Nature 449, 492–495 (2007 ).

    Not in our library10.1038/nature06127

48. 48.

    Hawley S. A.. The ancient drug salicylate directly activates AMP-activated protein kinase. Science 336, 918–922 (2012 ).

    Not in our library10.1126/science.1215327

49. 49.

    Endicott J. A., Noble M. E. & Johnson L. N. The structural basis for control of eukaryotic protein kinases. Annu. Rev. Biochem. 81, 587–613 (2012 ).

    Not in our library10.1146/annurev-biochem-052410-090317

50. 50.

    Jura N.. Catalytic control in the EGF receptor and its connection to general kinase regulatory mechanisms. Mol. Cell 42, 9–22 (2011 ).

    Not in our library10.1016/j.molcel.2011.03.004

51. 51.

    Chen L.. Conserved regulatory elements in AMPK. Nature 498, E8–10 (2013 ).

    Not in our library10.1038/nature12189

52. 52.

    Chen L.. Structural insight into the autoinhibition mechanism of AMP-activated protein kinase. Nature 459, 1146–1149 (2009 ).

    Not in our library10.1038/nature08075

53. 53.

    Neumann D., Woods A., Carling D., Wallimann T. & Schlattner U. Mammalian AMP-activated protein kinase: functional, heterotrimeric complexes by co-expression of subunits in Escherichia coli. Protein. Expr. Purif. 30, 230–237 (2003 ).

    Not in our library10.1016/s1046-5928(03)00126-8

54. 54.

    Otwinowski Z. & Minor W. Data Collection and Processing. Proceedings of the CCP4 Study Weekend 556–562SERC Daresbury Laboratory: Warrington, (1993 ).

    Not in our library

55. 55.
    Solving structures of protein complexes by molecular replacement with Phaser · 2006

    No notice
56. 56.
    Towards automated crystallographic structure refinement with phenix.refine · 2012

    No notice
57. 57.

    Emsley P. & Cowtan K. Coot: model-building tools for molecular graphics. Acta. Crystallogr. D 60, 2126–2132 (2004 ).

    Not in our library10.1107/s0907444904019158

58. 58.

    CCP4. The CCP4 suite: programs for protein crystallography. Acta. Crystallogr. D 50, 760–763 (1994 ).

    Not in our library10.1107/s0907444994003112

Cited by papers we hold 18

• Oxidative stress gene expression, DNA methylation, and gut microbiota interaction trigger Crohn’s disease: a multi-omics Mendelian randomization study · 2023
  No notice
• Emerging Role of cAMP/AMPK Signaling · 2022
  No notice
• The Metformin Mechanism on Gluconeogenesis and AMPK Activation: The Metabolite Perspective · 2020
  No notice
• Molecular Mechanisms of Adipogenesis: The Anti-adipogenic Role of AMP-Activated Protein Kinase · 2020
  No notice
• Transient Receptor Potential V Channels Are Essential for Glucose Sensing by Aldolase and AMPK · 2019
  Corrected
• The strange case of AMPK and cancer: Dr Jekyll or Mr Hyde? · 2019
  No notice
• Structure and Physiological Regulation of AMPK · 2018
  No notice
• AMPK in skeletal muscle function and metabolism · 2018
  No notice
• Mitochondria-derived ROS activate AMP-activated protein kinase (AMPK) indirectly · 2018
  No notice
• Keeping the home fires burning: AMP-activated protein kinase · 2018
  No notice
• Canagliflozin inhibits interleukin-1β-stimulated cytokine and chemokine secretion in vascular endothelial cells by AMP-activated protein kinase-dependent and -independent mechanisms · 2018
  No notice
• Phosphorylation of AMPK by upstream kinases is required for activity in mammalian cells · 2017
  No notice
• PARK2 Depletion Connects Energy and Oxidative Stress to PI3K/Akt Activation via PTEN S-Nitrosylation · 2017
  No notice
• Liver-Specific Activation of AMPK Prevents Steatosis on a High-Fructose Diet · 2017
  No notice
• Structural basis of allosteric and synergistic activation of AMPK by furan-2-phosphonic derivative C2 binding · 2016
  Not checked
• AMP ‐activated protein kinase: a cellular energy sensor that comes in 12 flavours · 2016
  No notice
• Differential regulation by AMP and ADP of AMPK complexes containing different γ subunit isoforms · 2016
  No notice
• AMPK antagonizes hepatic glucagon-stimulated cyclic AMP signalling via phosphorylation-induced activation of cyclic nucleotide phosphodiesterase 4B · 2016
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.